Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02164019 · ClinicalTrials.gov registry record · NA
A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur
A NA study of Proximal Femoral Metastases, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 73
- Enrollment target
- 6
- Study locations
NCT02164019: Active NA study of Proximal Femoral Metastases, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02164019 is a NA study of Proximal Femoral Metastases that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 73 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 6 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02164019, a NA study of Proximal Femoral Metastases, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to look at two different types of surgeries regularly used for treating cancer that has spread to and weakened the thigh bone (femur). Because it is not known which of these surgeries is best, the investigators will compare the results of the two procedures. They are looking to see if differences exist (after surgery) in function, quality of life, pain control, and possible complications.
Primary Outcome
Implant-specific differences in postoperative functional outcomes will be determined throughout the study period using Toronto Extremity Salvage Score (TESS); the primary outcome assessment will take place at the 12-week follow-up visit.
Conditions Studied
Interventions
- BEHAVIORAL questionnaires
- PROCEDURE long-stem cemented hemiarthroplasty (LSCH)
- PROCEDURE intramedullary nailing (IMN)
Study Locations (6)
New York
- Memorial Sloan Kettering Cancer Center 1275 York Avenue - New York
- University of Rochester Medical Center - Rochester
- SUNY Upstate Medical University - Syracuse
- Montefiore Medical Center - The Bronx
Michigan
- Spectrum Health Medical Group - Grand Rapids
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2014-06 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT02164019 still lists
NCT02164019 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 73 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Proximal Femoral Metastases appearing as the primary indexed condition, and to 3 interventions - of which questionnaires is the first listed.
NCT02164019 lists 6 locations in 3 states (New York, Michigan, North Carolina).
Frequently Asked Questions
What is clinical trial NCT02164019 about?
NCT02164019 is a clinical study titled "A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur". The purpose of this study is to look at two different types of surgeries regularly used for treating cancer that has spread to and weakened the thigh bone (femur). Because it is not known which of these surgeries is best, the investigators will compare the results of the two procedures. They are loo...
What is the current status of trial NCT02164019?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 73 participants. The study started on 2014-06. Estimated completion is 2026-06.
What conditions does trial NCT02164019 study?
This clinical trial studies the following conditions: Proximal Femoral Metastases.
What interventions are being tested in trial NCT02164019?
The interventions under investigation include: questionnaires (BEHAVIORAL), long-stem cemented hemiarthroplasty (LSCH) (PROCEDURE), intramedullary nailing (IMN) (PROCEDURE).
Who is sponsoring clinical trial NCT02164019?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02164019 being conducted?
This trial has 6 study locations across Michigan, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02164019's enrollment target sits among peer trials
73 1089th of 2000 higher than 912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia